Departement of Biochemistry, Maastricht University, Maastricht, The Netherlands.
Thromb Res. 2011 Feb;127 Suppl 3:S21-5. doi: 10.1016/S0049-3848(11)70007-X.
The recent development of semi-automated methods has revived interest in the thrombin generation test, a global assay that measures the overall tendency of a plasma sample to form thrombin after initiation of coagulation. The thrombin generation curve, which is characterised by a lag phase followed by the formation and subsequent inhibition of thrombin, reflects all three phases of coagulation (initiation, propagation and termination). However, the specific contribution of each coagulation factor or inhibitor to the assay outcome depends on the reaction conditions used (e.g. tissue factor concentration used to trigger coagulation, addition of thrombomodulin or activated protein C). Although several studies have shown a correlation between thrombin generation and the risk of bleeding or venous thrombosis, the application of thrombin generation assays to clinical decision-making is still hampered by standardisation problems. The present paper discusses these issues with particular reference to Calibrated Automated Thrombography.
最近半自动方法的发展重新引起了人们对凝血酶生成试验的兴趣,这是一种测量血浆样本在凝血起始后形成凝血酶的总体趋势的全局检测方法。凝血酶生成曲线的特点是滞后期,随后是凝血酶的形成和随后的抑制,反映了凝血的三个阶段(起始、传播和终止)。然而,每个凝血因子或抑制剂对检测结果的具体贡献取决于所用的反应条件(例如,用于触发凝血的组织因子浓度,添加血栓调节蛋白或活化蛋白 C)。尽管有几项研究表明凝血酶生成与出血或静脉血栓形成的风险之间存在相关性,但凝血酶生成检测在临床决策中的应用仍然受到标准化问题的阻碍。本文特别参考校准自动化血栓描记术讨论了这些问题。